Appropriate New Monoclonal for Immunocompromised Individuals to Prevent COVID-19.

Published Date: 25 Mar 2024

Ever since the FDA withdrew Evusheld's authorization last year, there hasn't been a similar choice.

Read Full News

Latest News

HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

2.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

5.

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot